These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6912944)

  • 21. Hyperprolactinemia and reduction in plasma titers of Hageman factor, prekallikrein, and high molecular weight kininogen in patients with acute myocardial infarction.
    La Follette L; Gordon EM; Mazur CA; Ratnoff OD; Yamashita TS
    J Lab Clin Med; 1987 Sep; 110(3):318-21. PubMed ID: 3649393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analyses of factor XII, prekallikrein and kallikrein inhibitory capacity in patients with laboratory signs of DIC.
    Egberg N; Hellgren M
    Scand J Clin Lab Invest Suppl; 1985; 178():25-9. PubMed ID: 3867118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and functional characterization of factor XII.
    Tans G; Rosing J
    Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma prekallikrein activity in patients with total hip arthroplasty.
    Hoffmann JJ; Kortmann JH
    Thromb Haemost; 1987 Dec; 58(4):1040-2. PubMed ID: 3445224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of Hageman factor (HG, factor XII) and plasma prekallikrein (Fletcher factor) by radioimmunoassays.
    Saito H
    Adv Exp Med Biol; 1979; 120A():165-72. PubMed ID: 573961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prekallikrein deficiency in a dog.
    Chinn DR; Dodds WJ; Selcer BA
    J Am Vet Med Assoc; 1986 Jan; 188(1):69-71. PubMed ID: 3632973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetylcysteine in rats: inhibition of activation of prekallikrein and factor XII--protection against dextran-induced blood pressure fall.
    Hoem NO; Briseid G
    Pharmacol Toxicol; 1987 Feb; 60(2):140-4. PubMed ID: 2437551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prekallikrein, HMW-kininogen and factor XII in various disease states.
    Deutsch E; Dragosics B; Kopsa H; Mannhalter C; Rainer H
    Thromb Res; 1983 Jul; 31(2):351-64. PubMed ID: 6356459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Examination of the plasma clotting activities--determination of contact factors XII, XI].
    Murakami M; Umeda T
    Rinsho Byori; 1969; 16():Suppl 16:66-74. PubMed ID: 5391587
    [No Abstract]   [Full Text] [Related]  

  • 30. Assembly of contact-phase factors on the surface of the human neutrophil membrane.
    Henderson LM; Figueroa CD; Müller-Esterl W; Bhoola KD
    Blood; 1994 Jul; 84(2):474-82. PubMed ID: 8025275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of contact factors in sickle cell disease.
    Gordon EM; Klein BL; Berman BW; Strandjord SE; Simon JE; Coccia PF
    J Pediatr; 1985 Mar; 106(3):427-30. PubMed ID: 3844465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initiation of the intrinsic coagulation and fibrinolytic pathways of man: the role of surfaces, hageman factor, prekallikrein, high molecular weight kininogen, and factor XI.
    Kaplan AP
    Prog Hemost Thromb; 1978; 4():127-75. PubMed ID: 362477
    [No Abstract]   [Full Text] [Related]  

  • 33. Kinin activation as a predictive assay for adverse reactions to radiographic contrast medium.
    Carr DH; Walker AC
    Acta Radiol Diagn (Stockh); 1984; 25(4):337-42. PubMed ID: 6567445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contact activation factors in plasma from women on estrogen replacement therapy after ovariohysterectomy.
    Fossum S; Hoem NO; Gjønnaess H; Briseid K
    Thromb Res; 1999 Feb; 93(4):161-70. PubMed ID: 10064271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on some coagulation factors (Hageman factor, plasma prekallikrein, and high molecular weight kininogen) in the normal newborn.
    Gordon EM; Ratnoff OD; Saito H; Gross S; Jones PK
    Am J Pediatr Hematol Oncol; 1980; 2(3):213-6. PubMed ID: 7435882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The contact phase of blood coagulation and renin activation in essential hypertension before and after captopril.
    Patrassi GM; Fallo F; Martinelli S; Mantero F; Boeri G; Girolami A
    Eur Heart J; 1984 Jul; 5(7):561-7. PubMed ID: 6383834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of hemostasis in ischemic cerebrovascular disease: IV. A five year follow-up of some blood coagulation parameters also including fibrinopeptide A, factor XII and prekallikrein.
    Mettinger KL
    Thromb Res; 1982 Jul; 27(2):155-60. PubMed ID: 6814002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pre-albumin activator of prekallikrein.
    Kaplan AP; Austen KF
    J Immunol; 1970 Oct; 105(4):802-11. PubMed ID: 5470521
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunoblotting studies of coagulation factor XII, plasma prekallikrein, and high molecular weight kininogen.
    Lämmle B; Berrettini M; Griffin JH
    Semin Thromb Hemost; 1987 Jan; 13(1):106-14. PubMed ID: 3494310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on contact factors. II. Contact activities in various diseases].
    Umeda T
    Nihon Ketsueki Gakkai Zasshi; 1968 Dec; 31(7):1173-9. PubMed ID: 5753798
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.